Twenty-seven scientific presentations related to ZOLL products and technology are scheduled to be presented during the American Heart Association (AHA) 2011 Resuscitation Science Symposium (ReSS) and Scientific Sessions November 12-15 in Orlando.
CIRC Trial results will be presented by Lars Wik, M.D., Ph.D., Principal Investigator of CIRC, Sunday, Nov. 13 at 8:00 a.m. in Room W415, Valencia Ballroom. The title of the presentation is “Comparison of Survival to Hospital Discharge between Integrated AutoPulse-CPR and Manual-CPR during Out-of-Hospital Cardiac Arrest of Presumed Cardiac Origin: The Circulation Improving Resuscitation Care (CIRC) Trial.” The LifeVest® Wearable Defibrillator will be discussed by Edwin T. Zishiri, M.D., Cleveland Clinic, on Monday, Nov. 14 at 3:45 p.m. in Room W204. The title of the presentation is “Use of the Wearable Cardioverter Defibrillator and Survival after Coronary Artery Revascularization in Patients with Left Ventricular Dysfunction.”
Additional presentations covering the AutoPulse® and the LifeVest Wearable Defibrillator, as well as other ZOLL technology including Real CPR Help®, See-Thru CPR®, and therapeutic temperature management products, are listed in the schedule below. A listing and schedule of all the presentations is available from the American Heart Association. All presentations will be available from the AHA and ZOLL at the conclusion of the AHA Scientific Sessions program.